Quick Answer
REPLIGEN CORP reported Stockholders Equity of $2.11 billion for fiscal year 2025.
REPLIGEN CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.11B | +6.8% |
| 2024 | $1.97B | +0.4% |
| 2023 | $1.96B | +2.8% |
| 2022 | $1.91B | +9.2% |
| 2021 | $1.75B | +14.4% |
| 2020 | $1.53B | +44.3% |
| 2019 | $1.06B | +72.2% |
| 2018 | $615.57M | +4.1% |
| 2017 | $591.55M | +250.5% |
| 2016 | $168.76M | +37.5% |
| 2015 | $122.75M | +9.9% |
| 2014 | $111.73M | +32.8% |
| 2013 | $84.12M | +0.0% |
| 2012 | $84.12M | +27.5% |
| 2011 | $65.99M | -1.6% |
| 2011 | $67.09M | +0.0% |
| 2010 | $67.09M | +1.5% |
| 2010 | $66.12M | -4.3% |
| 2009 | $69.12M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.08B | +3.3% | +1.0% |
| June 30, 2025 | $2.06B | +3.9% | +3.8% |
| March 31, 2025 | $1.99B | +1.0% | +0.6% |
| December 31, 2024 | $1.97B | +0.4% | -2.2% |
| September 30, 2024 | $2.02B | +2.2% | +1.6% |
| June 30, 2024 | $1.98B | +1.4% | +1.0% |
| March 31, 2024 | $1.97B | +1.3% | +0.0% |
| December 31, 2023 | $1.96B | +2.8% | -0.5% |
- REPLIGEN CORP showed an increase of +6.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, REPLIGEN CORP’s stockholders equity has grown by 2946.9% (from $69.12 million to $2.11 billion).
- The most recent figure is from REPLIGEN CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: